Lymphangioleiomyomatosis (LAM) is a rare form of Cystic Lung Disease, characterised by the abnormal growth of smooth muscle cells within the lungs. These cells can form cysts, leading to progressive ...

Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display ...

Cystic fibrosis (CF) and pulmonary fibrosis (PF) are two chronic conditions that damage the lungs. Treatment for both aims to improve breathing, manage symptoms, and prevent further lung damage. Your ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to deliver genetic therapies straight to lung cells. This innovation could transform ...

Yale researchers have identified a possible driver of the persistent inflammation that causes irreversible lung damage in patients with cystic fibrosis, a genetic disorder that impairs breathing and ...

Patients with cystic fibrosis without a lung transplant have elevated risks for cardiovascular disease, kidney disease, and cancer, and those with a lung transplant experience these risks earlier.